Form D · Pharmaceuticals
TRIMEL BIOPHARMA HOLDINGS INC.
Durants, Christ Church, C8 · CIK 0001477830
Offering snapshot reported Jul 29, 2011 · SEC filing
- Reported sold
- $6.27M Offering amount: $6.27M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 14, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 29, 2011 | Initial | $6,268,156 | No comparison | 14 | SEC filing |
| Apr 5, 2011 | Initial | $440,000 | No comparison | 0 | SEC filing |
| Dec 7, 2009 | Initial | $282,000 | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-163711
Source: Form D, filed Jul 29, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Liza A. Harridyal Sodha | Director, Executive |
| John Mccleery | Executive |
| Eugene Melnyk | Promoter |
| Robert Podruzny | Director, Executive |
| Arlene Quintyne | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Durants Business Centre Suite B
Durants, Christ Church, C8, BB17097
Durants, Christ Church, C8, BB17097